Paratek Pharmaceuticals' Series D Round

Paratek Pharmaceuticals raised a round of funding on May 13, 2002.

Paratek is a biopharmaceutical company focused on the development, and commercialization of innovative antibiotics. Paratek's lead product candidate, omadacycline, is a novel tetracycline-derived, bro…

Articles about Paratek Pharmaceuticals' Series D Round: